Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hoon Sim

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Diabetes Research and Clinical Practice|March 16, 2021
Incidence and disease course of new-onset diabetes mellitus in breast and colorectal cancer patients undergoing chemotherapy: A prospective multicenter cohort studyEun Kyung Lee, Bokyung Koo, Yul Hwangbo, et al.
Cancer Research and Treatment|May 16, 2024
A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast CancerChang Min Kim, Kyong Hwa Park, Yun Suk Yu, et al.
Theranostics|June 16, 2025
Loss of <i>SLC25A20</i> in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat DietSang Myung Woo, Ho Lee, Joon Hee Kang, et al.
Journal of Cancer Research and Clinical Oncology|May 6, 2014
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosisYu Jung Kim, Su-Jung Kim, June Koo Lee, et al.
Clinical Nuclear Medicine|November 6, 2018
Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture ParametersHyunjong Lee, Dong-Eun Lee, Sohyun Park, et al.
Breast Cancer (Tokyo, Japan)|January 23, 2023
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)Shigeru Imoto, Kun Wang, Xi-Wen Bi, et al.
Cancer Research|April 20, 2026
Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal AdenocarcinomaSang Myung Woo, Joon Hee Kang, Wonyoung Choi, et al.
Cancer Research and Treatment|February 21, 2018
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)In Hae Park, Seock-Ah Im, Kyung Hae Jung, et al.
Annals of Surgical Oncology|May 9, 2019
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 TrialSo-Youn Jung, Jai Hong Han, Soo Jin Park, et al.
JAMA Oncology|June 8, 2018
Incidence of Diabetes After Cancer Development: A Korean National Cohort StudyYul Hwangbo, Danbee Kang, Minwoong Kang, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Diabetes Research and Clinical Practice|March 16, 2021
Incidence and disease course of new-onset diabetes mellitus in breast and colorectal cancer patients undergoing chemotherapy: A prospective multicenter cohort studyEun Kyung Lee, Bokyung Koo, Yul Hwangbo, et al.
Cancer Research and Treatment|May 16, 2024
A 10-Gene Signature to Predict the Prognosis of Early-Stage Triple-Negative Breast CancerChang Min Kim, Kyong Hwa Park, Yun Suk Yu, et al.
Theranostics|June 16, 2025
Loss of <i>SLC25A20</i> in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat DietSang Myung Woo, Ho Lee, Joon Hee Kang, et al.
Journal of Cancer Research and Clinical Oncology|May 6, 2014
Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosisYu Jung Kim, Su-Jung Kim, June Koo Lee, et al.
Clinical Nuclear Medicine|November 6, 2018
Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture ParametersHyunjong Lee, Dong-Eun Lee, Sohyun Park, et al.
Breast Cancer (Tokyo, Japan)|January 23, 2023
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)Shigeru Imoto, Kun Wang, Xi-Wen Bi, et al.
Cancer Research|April 20, 2026
Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal AdenocarcinomaSang Myung Woo, Joon Hee Kang, Wonyoung Choi, et al.
Cancer Research and Treatment|February 21, 2018
Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)In Hae Park, Seock-Ah Im, Kyung Hae Jung, et al.
Annals of Surgical Oncology|May 9, 2019
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 TrialSo-Youn Jung, Jai Hong Han, Soo Jin Park, et al.
JAMA Oncology|June 8, 2018
Incidence of Diabetes After Cancer Development: A Korean National Cohort StudyYul Hwangbo, Danbee Kang, Minwoong Kang, et al.
Pageof 8